699x Apr 2026

: One of his notable studies focuses on patients who are ineligible for brachytherapy (internal radiation). He utilizes a "simultaneous integrated boost" technique to deliver higher doses of radiation more accurately using VMAT and Helical Tomotherapy.

As a recognized researcher with a verified ORCID profile , Sarpün’s contributions are part of a global, transparent record of scientific progress. His ongoing work continues to push the boundaries of how we use physics to fight one of humanity's most persistent health challenges. İsmail Hakkı SARPÜN (0000-0002-9788-699X) - ORCID : One of his notable studies focuses on

Advancing Precision in Cancer Care: The Work of İsmail Hakkı Sarpün His ongoing work continues to push the boundaries

For patients, these technical comparisons mean safer treatments with fewer side effects. When researchers identify which technology provides a better "dose distribution," they are essentially refining the "map" that radiation follows. This ensures that the life-saving energy hits the cancer with surgical precision, reducing the risk of damaging nearby vital organs. Tracking the Impact This ensures that the life-saving energy hits the

: By analyzing "dosimetry"—the calculation and assessment of the radiation dose received by the human body—his work helps hospitals choose the most effective machinery and software for specific patient needs.

: Research in medical physics is rarely a solo endeavor. Sarpün frequently collaborates with a diverse team of specialists, including M. İ. Sekmen and T. Koca, ensuring that the findings are grounded in both theoretical physics and practical clinical application. Why This Matters